324: Genentech's cancer pivot, Pfizer's sickle cell withdrawal, and a new schizophrenia drug
The Readout Loud
00:00
Innovations in Schizophrenia Treatment
This chapter delves into the upcoming FDA approval of CAR XT, a new schizophrenia drug from Coruna Therapeutics, highlighting the urgent need for innovative therapies in this area. It details the drug's development journey, its unique side effect profile, and the strategic acquisition by Bristol-Myers Squibb.
Transcript
Play full episode
